维普中文期刊产品整合服务
7篇 您的检索式:作者名="Chrispijn"
    题名 作者 年代 出处 被引量
1复杂并发症产生在简单并且 polycystic 肝包囊显示文摘 Liver cysts are common,affecting 5%-10% of the population.Most are asymptomatic,however 5% of patients develop symptoms,sometimes due to complications and will require intervention.There is no consensus on their management because complications are so uncommon.The aim of this study was to perform a collected review of how a series of complications were managed at our institutions.Six different patients presenting with rare complications of liver cysts were obtained from Hepatobiliary Units in the United Kingdom and The Netherlands.History and radiological imaging were obtained from case notes and computerised radiology.As a result,1 patient admitted with inferior vena cava obstruction was managed by cyst aspiration and lanreotide;1 patient with common bile duct obstruction was first managed by endoscopic retrograde cholangiopancreatography and stenting,followed by open fenestration;1 patient with ruptured cysts and significant medical co-morbidities was managed by percutaneous drainage;1 patient with portal vein occlusion and varices was managed by open liver resection;1 patient with infected cysts was treated with intravenous antibiotics and is awaiting liver transplantation.The final patient with a simple liver cyst mimicking a hydatid was managed by open liver resection.In conclusion,complications of cystic liver disease are rare,and we have demonstrated in this series that both operative and non-operative strategies have defined roles in management.The mainstays of treatment are either aspiration/sclerotherapy or,alternatively laparoscopic fenestration.Medical management with somatostatin analogues is a potentially new and exciting treatment option but requires further study.Christian Macutkiewicz Ricci Plastow Melissa Chrispijn Rafik Filobbos Basil A Ammori David J Sherlock Joost PH Drenth Derek A O’Reilly 2012World Journal of Hepatology2012,4,12:10
2Congenital fibrocystic liver diseases显示文摘Drenth JP Chrispijn M Bergmann C 0,,05:1
3Medical and surgical treatment options for polycystic liver disease 显示文摘Drenth JP Chrispijn M Nagorney DM 2010Hepatology2010,52,6:1
4Medical and sur- gical treatment options for polycystic liver diseasel 显示文摘Drenth J PH Chrispijn M Nagorney DM 2010Hepatolo- gy2010,52,6:1
5Medical and surgicaltreatment options for polycystic liver disease 显示文摘Drenth JP Chrispijn M Nagomey DM ei al 2010Hepatology2010,52,6:1
6Everolimus does not further reduce polycystic liver volume when added to long acting oetreotide: results from a randomized controlled trial显示文摘Chrispijn M Gevers TJ Hol JC 2013J Hepatol2013,59,1:1
7Medical and surgical treatment options for polycystic liver disease显示文摘Drenth JP Chrispijn M Nagorney DM 2010Hepatology2010,52,6:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费